PortalPublikationen[Fear of progression in breast cancer patients--validation o...

[Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)]

Standard

[Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)]. / Mehnert, Anja; Herschbach, Peter; Berg, Petra; Henrich, Gerhard; Koch-Gromus, Uwe.

in: Z PSYCHOSOM MED PSYC, Jahrgang 52, Nr. 3, 3, 2006, S. 274-288.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Mehnert, A, Herschbach, P, Berg, P, Henrich, G & Koch-Gromus, U 2006, '[Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)]', Z PSYCHOSOM MED PSYC, Jg. 52, Nr. 3, 3, S. 274-288. <http://www.ncbi.nlm.nih.gov/pubmed/17156600?dopt=Citation>

APA

Mehnert, A., Herschbach, P., Berg, P., Henrich, G., & Koch-Gromus, U. (2006). [Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)]. Z PSYCHOSOM MED PSYC, 52(3), 274-288. [3]. http://www.ncbi.nlm.nih.gov/pubmed/17156600?dopt=Citation

Vancouver

Mehnert A, Herschbach P, Berg P, Henrich G, Koch-Gromus U. [Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)]. Z PSYCHOSOM MED PSYC. 2006;52(3):274-288. 3.

Bibtex

@article{f65ed52d59414dc5b0cef29e8cb0220c,
title = "[Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)]",
abstract = "OBJECTIVES: Fear of progression is one of the most prevalent symptoms in cancer patients. The aim of this study was to validate the 12-item short version of the Fear of Progression Questionnaire (FoP-Q-SF). METHODS: A total of 1083 breast cancer patients were recruited by the Hamburg Cancer Register to fill out various questionnaires (response rate 67 %). RESULTS: Estimates of reliability were high (Cronbach's alpha = .87). The original one-factor structure was replicated. We used the HADS, the PCL-C, and the SF-8, among others, to validate the FoP-Q-SF. Significant positive correlations were found for fear of progression, anxiety and intrusion (r > .60) as well as for avoidance, hyperarousal and depression (r > or = .49). Moderate to high (negative) correlations were observed with health-related quality of life, in particular with the mental health dimensions (r > or = .48). Patients with cancer recurrence reported significant higher levels of fear of progression (p <.001). CONCLUSIONS: The short form of the Fear of Progression Questionnaire appears to be a reliable and valid instrument which can be recommended for further use in research and clinical care.",
author = "Anja Mehnert and Peter Herschbach and Petra Berg and Gerhard Henrich and Uwe Koch-Gromus",
year = "2006",
language = "Deutsch",
volume = "52",
pages = "274--288",
journal = "Z PSYCHOSOM MED PSYC",
issn = "1438-3608",
publisher = "Vandenhoeck and Ruprecht GmbH and Co. KG",
number = "3",

}

RIS

TY - JOUR

T1 - [Fear of progression in breast cancer patients--validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF)]

AU - Mehnert, Anja

AU - Herschbach, Peter

AU - Berg, Petra

AU - Henrich, Gerhard

AU - Koch-Gromus, Uwe

PY - 2006

Y1 - 2006

N2 - OBJECTIVES: Fear of progression is one of the most prevalent symptoms in cancer patients. The aim of this study was to validate the 12-item short version of the Fear of Progression Questionnaire (FoP-Q-SF). METHODS: A total of 1083 breast cancer patients were recruited by the Hamburg Cancer Register to fill out various questionnaires (response rate 67 %). RESULTS: Estimates of reliability were high (Cronbach's alpha = .87). The original one-factor structure was replicated. We used the HADS, the PCL-C, and the SF-8, among others, to validate the FoP-Q-SF. Significant positive correlations were found for fear of progression, anxiety and intrusion (r > .60) as well as for avoidance, hyperarousal and depression (r > or = .49). Moderate to high (negative) correlations were observed with health-related quality of life, in particular with the mental health dimensions (r > or = .48). Patients with cancer recurrence reported significant higher levels of fear of progression (p <.001). CONCLUSIONS: The short form of the Fear of Progression Questionnaire appears to be a reliable and valid instrument which can be recommended for further use in research and clinical care.

AB - OBJECTIVES: Fear of progression is one of the most prevalent symptoms in cancer patients. The aim of this study was to validate the 12-item short version of the Fear of Progression Questionnaire (FoP-Q-SF). METHODS: A total of 1083 breast cancer patients were recruited by the Hamburg Cancer Register to fill out various questionnaires (response rate 67 %). RESULTS: Estimates of reliability were high (Cronbach's alpha = .87). The original one-factor structure was replicated. We used the HADS, the PCL-C, and the SF-8, among others, to validate the FoP-Q-SF. Significant positive correlations were found for fear of progression, anxiety and intrusion (r > .60) as well as for avoidance, hyperarousal and depression (r > or = .49). Moderate to high (negative) correlations were observed with health-related quality of life, in particular with the mental health dimensions (r > or = .48). Patients with cancer recurrence reported significant higher levels of fear of progression (p <.001). CONCLUSIONS: The short form of the Fear of Progression Questionnaire appears to be a reliable and valid instrument which can be recommended for further use in research and clinical care.

M3 - SCORING: Zeitschriftenaufsatz

VL - 52

SP - 274

EP - 288

JO - Z PSYCHOSOM MED PSYC

JF - Z PSYCHOSOM MED PSYC

SN - 1438-3608

IS - 3

M1 - 3

ER -